Trends and Rapidity of Dose Tapering Among Patients Prescribed Long-term Opioid Therapy, 2008-2017

Authors:

Abstract
Millions of individuals in the United States use opioids for chronic pain.1 A 2016 Centers for Disease Control and Prevention (CDC) prescribing guideline encouraged nonopioid therapies for chronic pain, questioned daily dosages above 50 morphine milligram equivalents (MMEs), and advised avoidance of daily dosages of 90 MMEs or higher.2 The guideline recommended tapering of opioids when the risks outweigh the benefits.2-4 The overall volume of opioid prescribing decreased contemporaneously with the publication of the guideline.5 Local or regional policies limiting opioid prescriptions or enforcing clinician use of prescription drug monitoring programs may also encourage opioid tapering.6